SLBT Stock Summary and Trading Ideas (SL Science Holding Limited - | NASDAQ:SLBT)

SL Science Holding Ltd is a biomedical company specialized in developing cellular and gene therapies advancing regenerative medicine and cancer treatment. It utilizes immune stem cells to target cancer and bovine-derived milk exosomes to regenerate damaged tissues, thus potentially offering expansive medical applications for its products. With proprietary technologies such as Armed-T and Gamma Delta T cells, as well as exosome applications in skincare and cancer recovery. It operates in three segments namely Exosome products, CD-19 Armed-T products, and GDT cell therapy products. It derives revenue from Exosome products segment.

SL Science Holding Limited - trades on the NASDAQ stock market under the symbol SLBT.

As of August 26, 2026, SLBT stock price declined to $2.60 with 16,859 million shares trading.

SLBT has a market cap of $1.46 billion. This is considered a Small Cap stock.

SLBT support price is $2.47 and resistance is $2.81 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SLBT shares will trade within this expected range on the day.